A Pharmacokinetic Study of PLENVU® in Healthy Subjects
Status:
Completed
Trial end date:
2020-10-05
Target enrollment:
Participant gender:
Summary
This study characterises the pharmacokinetic (PK) profile of the active ingredients of PLENVU
(NER1006) and their related substances/metabolites. Subjects will receive PLENVU.